Home › Leucemia mieloide acuta › Ohio › Cincinnati
Studi clinici su Leucemia mieloide acuta a Cincinnati, OH
20 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Cincinnati e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- e altri 3
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
In reclutamentoStudio osservazionale
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- Oncology Hematology Care, Cincinnati
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
In reclutamentoStudio osservazionale
- University of Cincinnati, Cincinnati
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
In reclutamentoFase 3
- US-Cincinnati OH-CINCY, Cincinnati
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- US-Cincinnati OH-CINCY, Cincinnati
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
In reclutamentoFase 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi di distanza
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
In reclutamentoFase 3
- University of Cincinnati Medical Center (University Hospital), Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Cincinnati Children's Hospital, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
In reclutamentoFase 1
- Cincinnati Children's Hospital, Cincinnati
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
In reclutamentoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
In reclutamentoFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
In reclutamentoFase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
In reclutamentoFase 1
- Oncology Hematology Care, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
In reclutamentoFase 1
- University of Cincinnati, Cincinnati
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Baldwin Park, CA40 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Altri studi a Cincinnati
- Cancro del polmone non a piccole cellule35 studi
- Cancro (tutti i tipi)27 studi
- Cancro al seno25 studi
- Insufficienza cardiaca24 studi
- Cancro colorettale21 studi
- Cancro metastatico20 studi
- Cancro ovarico19 studi
- Cancro ai polmoni19 studi
- Obesità19 studi
- Cancro alla prostata18 studi
- Mieloma multiplo17 studi
- Melanoma17 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.